Pages that link to "Q40365717"
Jump to navigation
Jump to search
The following pages link to Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. (Q40365717):
Displaying 50 items.
- Evaluation of HIF-1 inhibitors as anticancer agents (Q28253053) (← links)
- Effects of histone deacetylase inhibitors on HIF-1 (Q28273896) (← links)
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics (Q29615944) (← links)
- Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. (Q30358961) (← links)
- Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells (Q30875270) (← links)
- Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds (Q33359943) (← links)
- Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical study (Q33384970) (← links)
- Real-time imaging of HIF-1alpha stabilization and degradation (Q33426848) (← links)
- Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis (Q33437895) (← links)
- Microtubular stability affects cardiomyocyte glycolysis by HIF-1alpha expression and endonuclear aggregation during early stages of hypoxia (Q33540640) (← links)
- Beta tubulin affects the aryl hydrocarbon receptor function via an Arnt-mediated mechanism (Q33664841) (← links)
- VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma (Q34355786) (← links)
- Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors (Q34382527) (← links)
- Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities. (Q34419792) (← links)
- Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression (Q34483117) (← links)
- Dynamics of tumor hypoxia in response to patupilone and ionizing radiation (Q34516719) (← links)
- ECM-dependent HIF induction directs trophoblast stem cell fate via LIMK1-mediated cytoskeletal rearrangement (Q34599786) (← links)
- Novel microtubule-targeting agents - the epothilones. (Q34611212) (← links)
- LIMK1 regulates human trophoblast invasion/differentiation and is down-regulated in preeclampsia (Q34646945) (← links)
- Effects of hypoxia on human cancer cell line chemosensitivity (Q34799788) (← links)
- Role of the cytoskeleton in formation and maintenance of angiogenic sprouts (Q34829230) (← links)
- Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1. (Q34974178) (← links)
- Characterization of mRNA-cytoskeleton interactions in situ using FMTRIP and proximity ligation (Q34990175) (← links)
- Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents (Q35108206) (← links)
- A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways (Q35163974) (← links)
- Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes. (Q35172172) (← links)
- Microtubules regulate hypoxia-inducible factor-1α protein trafficking and activity: implications for taxane therapy (Q35874392) (← links)
- Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer (Q35944520) (← links)
- The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression (Q36134768) (← links)
- A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration (Q36447016) (← links)
- Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells (Q36470446) (← links)
- 2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation (Q36485290) (← links)
- Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents (Q36772390) (← links)
- Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development (Q36861319) (← links)
- Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis (Q36897028) (← links)
- 2-Methoxyestradiol Alleviates Experimental Autoimmune Uveitis by Inhibiting Lymphocytes Proliferation and T Cell Differentiation. (Q36924163) (← links)
- Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma (Q36931508) (← links)
- EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. (Q36950656) (← links)
- Mechanisms of disease: Intracrine physiology in the cardiovascular system (Q36950886) (← links)
- Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia (Q36970574) (← links)
- Plants and their active compounds: natural molecules to target angiogenesis (Q37059810) (← links)
- ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling (Q37109919) (← links)
- Unexpected antitumorigenic effect of fenbendazole when combined with supplementary vitamins (Q37204028) (← links)
- Drug development from marine natural products (Q37354836) (← links)
- A truncated Ah receptor blocks the hypoxia and estrogen receptor signaling pathways: a viable approach for breast cancer treatment (Q37386896) (← links)
- Uterine fibroids and current clinical challenges (Q37437333) (← links)
- Hypoxia, notch signalling, and prostate cancer. (Q37589392) (← links)
- Anti-angiogenic effects of dietary isothiocyanates: Mechanisms of action and implications for human health (Q37801027) (← links)
- Glioblastoma, cancer stem cells and hypoxia (Q37807468) (← links)
- The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. (Q37884379) (← links)